Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial

Yung Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C. Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh, Giuseppe Aprile, Evgeny Kulikov, Julie Hill, Michaela Lehle, Josef Rüschoff, Yoon Koo Kang

Research output: Contribution to journalArticlepeer-review

4463 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences